« Back to Record
Coghlan, J. G., Simonneau, G., Vachiery, J.-L., Blair, C., Gillies, H., Miller, K. K., Harris, J. H. N., Langley, J., Rubin, L., Galie, N., Barberà, J. A., Frost, A., Ghofrani, H. A., Hoeper, M. M., Kuwana, M., McLaughlin, V., & Peacock, A. J. (2017). Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): Subgroup analysis from the AMBITION trial. Annals of the Rheumatic Diseases, 76(7), 1219-1227. doi:10.1136/annrheumdis-2016-210236
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253150



